French charity attacks Gilead patent for hepatitis drug
French charity Medecins du Monde (MdM) on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly.
Feb 10, 2015
0
7